Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT06820190

Analgesic Efficacy of Multiple Mid-Transverse Process to Pleura (MTP) Block and PCA in Idiopathic Scoliosis Patients Undergoing Posterior Spinal Fusion

Led by Tanta University · Updated on 2026-01-07

40

Participants Needed

1

Research Sites

93 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This study aims to compare the analgesic efficacy of multiple mid-transverse process to pleura (MTP) block and PCA in idiopathic scoliosis patients undergoing posterior spinal fusion surgery.

CONDITIONS

Official Title

Analgesic Efficacy of Multiple Mid-Transverse Process to Pleura (MTP) Block and PCA in Idiopathic Scoliosis Patients Undergoing Posterior Spinal Fusion

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18 years or older
  • Both sexes
  • American Society of Anesthesiology (ASA) physical status I-II
  • Idiopathic scoliosis patients undergoing posterior spinal fusion surgery
Not Eligible

You will not qualify if you...

  • Infection at the block site
  • Known allergy to study drugs
  • Coagulation disorder
  • History of psychiatric illness
  • Pre-existing neurological deficits
  • Morbid obesity (body mass index >40 kg/m2)
  • Any pre-operative pain or history of chronic pain
  • History of regular analgesic use

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Tanta University

Tanta, El-Gharbia, Egypt, 31527

Actively Recruiting

Loading map...

Research Team

M

Mohammed S Elsharkawy, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here